ERCC1 and invasive ductal breast carcinoma: The positive rates of MGMT, ERCC1, hMSH2, and hMLH1 (Figure 2) were significantly lower in ductal adenocarcinoma than those in non-cancerous pancreatic tissues in group A + group B (P <0.01 or P <0.05).